These IGF-I actions, taken together with its neuroprotective effects following CNS and peripheral nerve injury, suggest that it may be of therapeutic benefit in a wide variety of disorders affecting the nervous system
Optimization Phase (Months 4-6) What to expect: More significant changes in body composition Improved muscle tone and reduced body fat Enhanced skin quality Cognitive and mood improvements Sustained energy improvements Lab monitoring: Repeat comprehensive hormone panel at 6 months including IGF-1, metabolic markers, and related hormones
L-Tartrate: Some supplements combine L-carnitine L-tartarate (LCLT) for superior absorption and faster muscle recovery
*In a clinical study by Ribeiro et al
People taking GLP-1 medications commonly report reduced food cravings, less emotional eating, and a quieting of the constant mental preoccupation with food that researchers call "food noise." Animal studies have also shown that GLP-1 receptor activation reduces the rewarding properties of high-calorie food in the brain findings confirmed in a landmark randomized, placebo-controlled neuroimaging study in humans ( van Bloemendaal et al., Diabetes, 2014 )
TB-500 was initially studied for its ability to regenerate heart tissue after heart attacks